Dublin, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability.
Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.
Advantages of digital manufacturing includes:
- Increased Monitoring
- Data Collection and Handling
- Connectivity
- Computer power
- Process control algorithms
- Automation
Market Dynamics
Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies.
Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs.
This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation.
Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT), artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing.
Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future
Key features of the study:
- This report provides an in-depth analysis of the global digital biomanufacturing market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global digital biomanufacturing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMERIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global digital biomanufacturing market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global digital biomanufacturing market
| Report Attribute | Details |
| No. of Pages | 243 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $17.92 Billion |
| Forecasted Market Value (USD) by 2030 | $38.14 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Development
- Regulatory Scenario
- PEST Analysis
- Porter's Analysis
- Advances in Digital Biomanufacturing
- Overview of Digital Biomanufacturing
4. Global Digital Biomanufacturing Market - Impact of Coronavirus (Covid-19) Pandemic
- Government Initiative to Combat Covid-19
- COVID 19 Epidemiology
- COVID 19 Impact on Supply Chain
5. Global Digital Biomanufacturing Market, By Type, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Manufacturing Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Analytical and Process Control Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Digital Biomanufacturing Market, By Application, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Bioprocess Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Biomanufacturing Process Automation and Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Digital Biomanufacturing Market, By Region, 2017-2030 (US$ Million)
8. Competitive Landscape
- Company Profiles
- 3M
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- ABB
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cytiva
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Siemens
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- immersciobio
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- BIOMERIEUX
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Agilent Technologies, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Culture Biosciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/jletzx
Attachment
